The LDI is among Canada’s leading health research institutes. Through their fundamental and clinical investigations, our scientists and clinicians make significant discoveries, lead important provincial and national research programs, and train emerging scientists who, themselves, are recognized for the excellence of their work, contributing to the health and well-being of patients in Quebec, Canada, and around the world.
At the Lady Davis Institute for Medical Research (LDI), equity, diversity and inclusion are at the heart of who we are. We are committed to provide people working in the LDI community with exemplary, highest quality of work and learning environments that are healthy, equitable and inclusive, free from all forms of discrimination and where every person can feel welcomed and recognized, but also involved and contributing to the present and the future of the LDI.
Discover our 200+ regular and associated investigators and their research, as well as the many services we provide across the spectrum of the research process.
We offer the 250+ graduate and postdoctoral students who come to the LDI each year an open, collaborative, and multidisciplinary training environment that fosters excellence.
The close collaboration between researchers, clinicians, and patients is at the basis of the most successful research programs and clinical trials at the LDI.
At the Lady Davis Institute for Medical Research (LDI), equity, diversity and inclusion are at the heart of who we are. We are committed to provide people working in the LDI community with exemplary, highest quality of work and learning environments that are healthy, equitable and inclusive, free from all forms of discrimination and where every person can feel welcomed and recognized, but also involved and contributing to the present and the future of the LDI.
🧬 A 300-year-old "jumping gene" may explain elevated pancreatic cancer risk in French Canadians — previously undetectable by standard genetic tests.
🔬 👉 https://rimuhc.ca/en/-/jumping-gene-helps-explain-elevated-pancreatic-cancer-risk-in-french-canadians
🧬 Un « gène sauteur » vieux de 300 ans pourrait expliquer le risque accru de cancer du pancréas chez les Canadiens français — jusqu'ici indétectable par les tests génétiques standards.
🔬 👉 https://rimuhc.ca/fr/-/l-existence-d-un-gene-sauteur-pourrait-expliquer-le-risque-accru-de-cancer-du-pancreas-chez-les-canadiens-francais
Selon un sondage national, le remplacement du test Pap, utilisé de longue date, par le test de dépistage du virus du papillome humain nécessitera une communication optimale.
🔗https://mcgill.ca/x/5PP
Last‑resort antibiotics are failing and resistant infections are rising.
Yves Longtin & Dao Nguyen are tracking how these bacteria spread in hospitals, with support from Pathy & MI4 seed funding.
A critical step toward stronger infection prevention. 🏥🦠
👉https://linktr.ee/mi4innovates